We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

189 hedge funds and large institutions have $1.43B invested in Corcept Therapeutics in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 65 increasing their positions, 46 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

262% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 13

139% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $4.89M

73% more capital invested

Capital invested by funds: $824M → $1.43B (+$605M)

41% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 46

21% more funds holding

Funds holding: 156 → 189 (+33)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

3.67% more ownership

Funds ownership: 61.7% → 65.37% (+3.7%)

Holders
189
Holders Change
+33
Holders Change %
+21.15%
% of All Funds
4.71%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
47
Increased
65
Reduced
46
Closed
13
Calls
$11.7M
Puts
$4.89M
Net Calls
+$6.79M
Net Calls Change
+$5.06M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$26.8M
2
Renaissance Technologies
Renaissance Technologies
New York
+$14.7M
3
Wells Fargo
Wells Fargo
California
+$9.23M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$8.89M
5
AAM
AMI Asset Management
California
+$7.87M

Top Sellers

1
Federated Hermes
Federated Hermes
Pennsylvania
-$33.2M
2
CCM
Consonance Capital Management
New York
-$28.7M
3
MWNA
Marshall Wace North America
New York
-$10.4M
4
ISL
Ingalls & Snyder LLC
New York
-$6.46M
5
Morgan Stanley
Morgan Stanley
New York
-$6.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
126
Bank of Montreal
Ontario, Canada
$524K -$116K -7,770 -22%
William Blair & Company
127
William Blair & Company
Illinois
$521K – – –
HI
128
HBK Investments
Texas
$513K -$716K -48,006 -64%
DT
129
Diversified Trust
Tennessee
$506K +$391K +26,200 New
AA
130
ALPS Advisors
Colorado
$506K +$391K +26,212 New
Royal Bank of Canada
131
Royal Bank of Canada
Ontario, Canada
$505K +$57.4K +3,848 +17%
Squarepoint
132
Squarepoint
New York
$493K -$208K -13,939 -35%
CSS
133
Cubist Systematic Strategies
Connecticut
$484K -$142K -9,517 -28%
CI
134
Cavalier Investments
Georgia
$483K +$373K +25,000 New
SSWM
135
Sheets Smith Wealth Management
North Carolina
$458K -$3.23K -217 -0.9%
Legal & General Group
136
Legal & General Group
United Kingdom
$458K +$9.38K +629 +3%
CCIA
137
Campbell & Co Investment Adviser
Maryland
$450K +$131K +8,770 +60%
QT
138
Quantbot Technologies
New York
$440K +$128K +8,568 +60%
AIMCA
139
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$438K – – –
Schroder Investment Management Group
140
Schroder Investment Management Group
United Kingdom
$432K – – –
PCM
141
Penserra Capital Management
California
$417K +$322K +21,624 New
GT
142
Glenmede Trust
Pennsylvania
$414K +$320K +21,462 New
MCM
143
Matarin Capital Management
New York
$402K -$29.1K -1,954 -9%
BSW
144
Buckingham Strategic Wealth
Missouri
$386K – – –
Jacobs Levy Equity Management
145
Jacobs Levy Equity Management
New Jersey
$382K +$295K +19,810 New
GCIA
146
Gabelli & Co Investment Advisers
New York
$345K -$61.1K -4,100 -19%
Robeco Institutional Asset Management
147
Robeco Institutional Asset Management
Netherlands
$340K – – –
SEI Investments
148
SEI Investments
Pennsylvania
$339K +$203K +13,614 +345%
JIP
149
Jaffetilchin Investment Partners
Florida
$339K +$262K +17,559 New
PM
150
Parametrica Management
Hong Kong
$312K +$241K +16,154 New
4 5
6
7 8

CORT Hedge Fund Activity: Q3 2017 in Review

189 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2017, worth a combined $1.43B — up 73% from $824M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new CORT positions and 13 closed out — a net gain of 34 holders — while 65 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $26.8M. The largest seller was Federated Hermes, cutting an estimated $33.2M.

  • 189 institutional investors held Corcept Therapeutics (CORT) as of Q3 2017, up from 156 in Q2 2017.
  • Funds reported $1.43B of Corcept Therapeutics stock for Q3 2017, up 73% quarter-over-quarter.
  • 47 funds opened new Corcept Therapeutics positions in Q3 2017 and 13 closed out, a net change of +34 holders.
  • The largest Corcept Therapeutics buyer in Q3 2017 was Vanguard Group, an estimated $26.8M added.
  • The largest Corcept Therapeutics seller in Q3 2017 was Federated Hermes, an estimated $33.2M sold.

Based on aggregated 13F filings for Q3 2017.